Pier Marco Piatti

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: Comparison to hypocaloric high-carbohydrate diet

Pier Marco Piatti, Lorenzo Monti, Fulvio Magni et al. · Metabolism · 1994 · 228 citations

Obesity, Metabolic Syndrome, Nutrition +11

Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy

Gabriele Fragasso, Pier Marco Piatti, Lorenzo Monti et al. · American Heart Journal · 2003 · 203 citations

Cardiovascular Toxicity, Metabolic Syndrome, Cardiovascular Disease +7

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode et al. · The Lancet Diabetes & Endocrinology · 2021 · 163 citations · Full text

Inflammation, β-Cell Function, Diabetes Management +7

Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia

Emanuela Setola, L. Monti, Elena Galluccio et al. · European Journal of Endocrinology · 2004 · 155 citations · Full text